Literature DB >> 34299101

COVID-19 in Children: Expressions of Type I/II/III Interferons, TRIM28, SETDB1, and Endogenous Retroviruses in Mild and Severe Cases.

Pier-Angelo Tovo1, Silvia Garazzino2, Valentina Daprà3, Giulia Pruccoli1, Cristina Calvi1,3, Federica Mignone2, Carla Alliaudi1,3, Marco Denina1, Carlo Scolfaro2, Marisa Zoppo2, Francesco Licciardi1, Ugo Ramenghi1, Ilaria Galliano1,3, Massimiliano Bergallo1,3.   

Abstract

Children with the new coronavirus disease 2019 (COVID-19) have milder symptoms and a better prognosis than adult patients. Several investigations assessed type I, II, and III interferon (IFN) signatures in SARS-CoV-2 infected adults, however no data are available for pediatric patients. TRIM28 and SETDB1 regulate the transcription of multiple genes involved in the immune response as well as of human endogenous retroviruses (HERVs). Exogenous viral infections can trigger the activation of HERVs, which in turn can induce inflammatory and immune reactions. Despite the potential cross-talks between SARS-CoV-2 infection and TRIM28, SETDB1, and HERVs, information on their expressions in COVID-19 patients is lacking. We assessed, through a PCR real time Taqman amplification assay, the transcription levels of six IFN-I stimulated genes, IFN-II and three of its sensitive genes, three IFN-lIIs, as well as of TRIM28, SETDB1, pol genes of HERV-H, -K, and -W families, and of env genes of Syncytin (SYN)1, SYN2, and multiple sclerosis-associated retrovirus (MRSV) in peripheral blood from COVID-19 children and in control uninfected subjects. Higher expression levels of IFN-I and IFN-II inducible genes were observed in 36 COVID-19 children with mild or moderate disease as compared to uninfected controls, whereas their concentrations decreased in 17 children with severe disease and in 11 with multisystem inflammatory syndrome (MIS-C). Similar findings were found for the expression of TRIM-28, SETDB1, and every HERV gene. Positive correlations emerged between the transcriptional levels of type I and II IFNs, TRIM28, SETDB1, and HERVs in COVID-19 patients. IFN-III expressions were comparable in each group of subjects. This preserved induction of IFN-λs could contribute to the better control of the infection in children as compared to adults, in whom IFN-III deficiency has been reported. The upregulation of IFN-I, IFN-II, TRIM28, SETDB1, and HERVs in children with mild symptoms, their declines in severe cases or with MIS-C, and the positive correlations of their transcription in SARS-CoV-2-infected children suggest that they may play important roles in conditioning the evolution of the infection.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; SETDB1; TRIM28; children; human endogenous retroviruses; interferon

Year:  2021        PMID: 34299101     DOI: 10.3390/ijms22147481

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  12 in total

Review 1.  p53/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics).

Authors:  Daniela Milani; Lorenzo Caruso; Enrico Zauli; Adi Mohammed Al Owaifeer; Paola Secchiero; Giorgio Zauli; Donato Gemmati; Veronica Tisato
Journal:  Front Pharmacol       Date:  2022-05-27       Impact factor: 5.988

2.  Enhanced Expression of Human Endogenous Retroviruses, TRIM28 and SETDB1 in Autism Spectrum Disorder.

Authors:  Pier-Angelo Tovo; Chiara Davico; Daniele Marcotulli; Benedetto Vitiello; Valentina Daprà; Cristina Calvi; Paola Montanari; Andrea Carpino; Ilaria Galliano; Massimiliano Bergallo
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

3.  Immune-Related Protein Interaction Network in Severe COVID-19 Patients toward the Identification of Key Proteins and Drug Repurposing.

Authors:  Pakorn Sagulkoo; Apichat Suratanee; Kitiporn Plaimas
Journal:  Biomolecules       Date:  2022-05-11

4.  Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2.

Authors:  Ma'ayan Israeli; Yaara Finkel; Yfat Yahalom-Ronen; Nir Paran; Theodor Chitlaru; Ofir Israeli; Inbar Cohen-Gihon; Moshe Aftalion; Reut Falach; Shahar Rotem; Uri Elia; Ital Nemet; Limor Kliker; Michal Mandelboim; Adi Beth-Din; Tomer Israely; Ofer Cohen; Noam Stern-Ginossar; Adi Bercovich-Kinori
Journal:  Nat Commun       Date:  2022-04-25       Impact factor: 17.694

Review 5.  Human Endogenous Retroviruses as Gene Expression Regulators: Insights from Animal Models into Human Diseases.

Authors:  Serpen Durnaoglu; Sun-Kyung Lee; Joohong Ahnn
Journal:  Mol Cells       Date:  2021-12-31       Impact factor: 5.034

6.  SARS-CoV-2 infection mediates differential expression of human endogenous retroviruses and long interspersed nuclear elements.

Authors:  Jez L Marston; Matthew Greenig; Manvendra Singh; Matthew L Bendall; Rodrigo R R Duarte; Cédric Feschotte; Luis P Iñiguez; Douglas F Nixon
Journal:  JCI Insight       Date:  2021-12-22

Review 7.  KAP1/TRIM28: Transcriptional Activator and/or Repressor of Viral and Cellular Programs?

Authors:  Keyera Randolph; Usman Hyder; Iván D'Orso
Journal:  Front Cell Infect Microbiol       Date:  2022-02-23       Impact factor: 6.073

8.  Serum IL-28A/IFN-λ2 is linked to disease severity of COVID-19.

Authors:  Yosuke Fukuda; Tetsuya Homma; Hideki Inoue; Yuiko Goto; Yoko Sato; Hitoshi Ikeda; Chisato Onitsuka; Hiroki Sato; Kaho Akimoto; Takaya Ebato; Hiromitsu Suganuma; Tomoko Kawahara; Hatsuko Mikuni; Yoshitaka Uchida; Shintaro Suzuki; Akihiko Tanaka; Hironori Sagara
Journal:  Sci Rep       Date:  2022-03-31       Impact factor: 4.379

9.  Increased Presence of Antibodies against Type I Interferons and Human Endogenous Retrovirus W in Intensive Care Unit COVID-19 Patients.

Authors:  Elena Rita Simula; Maria Antonietta Manca; Marta Noli; Somaye Jasemi; Stefano Ruberto; Sergio Uzzau; Salvatore Rubino; Pietro Manca; Leonardo A Sechi
Journal:  Microbiol Spectr       Date:  2022-07-19

Review 10.  Syncytin, envelope protein of human endogenous retrovirus (HERV): no longer 'fossil' in human genome.

Authors:  Serpen Durnaoglu; Sun-Kyung Lee; Joohong Ahnn
Journal:  Anim Cells Syst (Seoul)       Date:  2022-01-12       Impact factor: 1.815

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.